233 related articles for article (PubMed ID: 35457036)
1. The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases.
Cuesta AM; Gallardo-Vara E; Casado-Vela J; Recio-Poveda L; Botella LM; Albiñana V
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457036
[TBL] [Abstract][Full Text] [Related]
2. Drug repurposing in rare diseases: Myths and reality.
Fetro C; Scherman D
Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
[TBL] [Abstract][Full Text] [Related]
3. Propranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies.
Albiñana V; Gallardo-Vara E; Casado-Vela J; Recio-Poveda L; Botella LM; Cuesta AM
J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956154
[TBL] [Abstract][Full Text] [Related]
4. Drug repositioning for rare diseases: Knowledge-based success stories.
Scherman D; Fetro C
Therapie; 2020 Apr; 75(2):161-167. PubMed ID: 32164975
[TBL] [Abstract][Full Text] [Related]
5. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
[TBL] [Abstract][Full Text] [Related]
6. Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta.
Lee JC; Modiri O; England RW; Shawber CJ; Wu JK
Plast Reconstr Surg; 2021 Apr; 147(4):875-885. PubMed ID: 33776033
[TBL] [Abstract][Full Text] [Related]
7. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
[TBL] [Abstract][Full Text] [Related]
8. [Two news drugs (ivacaftor & bedaquiline), one biomarker (florbetapir) and a re-positioned drug (propranolol) on the market].
Monneret C
Ann Pharm Fr; 2014 Jul; 72(4):229-37. PubMed ID: 24997884
[TBL] [Abstract][Full Text] [Related]
9. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.
Albiñana V; Recio-Poveda L; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2012 Jul; 108(1):41-53. PubMed ID: 22552254
[TBL] [Abstract][Full Text] [Related]
10. Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
Filippi L; Dal Monte M; Casini G; Daniotti M; Sereni F; Bagnoli P
Med Res Rev; 2015 May; 35(3):619-52. PubMed ID: 25523517
[TBL] [Abstract][Full Text] [Related]
11. Infantile Hemangiomas: Pathogenesis and Review of Propranolol Use.
Laken PA
Adv Neonatal Care; 2016 Apr; 16(2):135-42. PubMed ID: 26945282
[TBL] [Abstract][Full Text] [Related]
12. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
Pan WK; Li P; Guo ZT; Huang Q; Gao Y
Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment for small abdominal aortic aneurysms.
Rughani G; Robertson L; Clarke M
Cochrane Database Syst Rev; 2012 Sep; (9):CD009536. PubMed ID: 22972146
[TBL] [Abstract][Full Text] [Related]
14. Propranolol-resistant infantile hemangioma successfully treated with sirolimus.
Dávila-Osorio VL; Iznardo H; Roé E; Puig L; Baselga E
Pediatr Dermatol; 2020 Jul; 37(4):684-686. PubMed ID: 32323340
[TBL] [Abstract][Full Text] [Related]
15. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
16. RDKG-115: Assisting drug repurposing and discovery for rare diseases by trimodal knowledge graph embedding.
Zhu C; Xia X; Li N; Zhong F; Yang Z; Liu L
Comput Biol Med; 2023 Sep; 164():107262. PubMed ID: 37481946
[TBL] [Abstract][Full Text] [Related]
17. [Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations].
Sánchez-Carpintero I; Ruiz-Rodriguez R; López-Gutiérrez JC
Actas Dermosifiliogr; 2011 Dec; 102(10):766-79. PubMed ID: 21774911
[TBL] [Abstract][Full Text] [Related]
18. Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review.
Kardasevic M; Dinarevic SM
Med Arch; 2021 Apr; 75(2):158-161. PubMed ID: 34219878
[TBL] [Abstract][Full Text] [Related]
19. Propranolol for infantile haemangiomas: a review.
Starkey E; Shahidullah H
Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
[TBL] [Abstract][Full Text] [Related]
20. Propranolol treatment for infantile hemangiomas.
Buckmiller LM
Curr Opin Otolaryngol Head Neck Surg; 2009 Dec; 17(6):458-9. PubMed ID: 19858718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
